Venus Remedies Limited — Results, 05-02-2025: Integrated Filing- Financial

Venus Remedies Limited has announced a board meeting to discuss the financial results for the quarter and nine-month period ended 31 December 2024. The company reported revenue from operations of ₹172.54 crore and a net profit of ₹24.08 crore for the quarter. A notable item includes the write-off of a time-barred Foreign Currency Convertible Bond liability of ₹38.68 crore, which has been transferred to the Capital Reserve. This could improve the company's financial position but may raise questions about past liabilities. Investors might view this as a positive outlook, reflecting strategic adjustments and stronger governance in financial management.